Post-Johnson & Johnson, government plans law to put onus on medical companies

The adverse event also has certain riders that it has not been reported earlier (by other patients) when the device was under clinical trial and is not part of the package insert (leaflet) of the device.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2NTVNPu
via IFTTT